Paranta Biosciences

Paranta is an Australian unlisted, public company focused on developing transformative biotherapeutics based on follistatin, targeting diseases of major unmet need including acute kidney injury.

Investors

About Paranta

Click here to learn more about Paranta

Presentations

Click here to view Paranta's presentations

Annual Reports

Click here to view Paranta's annual reports

Recent Announcements

Click here to view Paranta's recent announcements

Email Alerts

Sign up now

FAQs

Click here to view FAQs

address

Paranta Biosciences Limited
Suite 549, 1 Queens Rd
Melbourne, VIC 3004
Australia
T (03) 9863 9070

email alerts

quick search